125 related articles for article (PubMed ID: 38613785)
1. Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation.
Yamasaki T; Nishiyama A; Kurogi N; Nishimura K; Nishida S; Kurotaki D; Ban T; Ramilowski JA; Ozato K; Toyoda A; Tamura T
Cell Rep; 2024 Apr; 43(4):114107. PubMed ID: 38613785
[TBL] [Abstract][Full Text] [Related]
2. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
[TBL] [Abstract][Full Text] [Related]
3.
Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
[TBL] [Abstract][Full Text] [Related]
4. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
[TBL] [Abstract][Full Text] [Related]
5. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
[TBL] [Abstract][Full Text] [Related]
6. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
Murakami K; Sasaki H; Nishiyama A; Kurotaki D; Kawase W; Ban T; Nakabayashi J; Kanzaki S; Sekita Y; Nakajima H; Ozato K; Kimura T; Tamura T
Nat Immunol; 2021 Mar; 22(3):301-311. PubMed ID: 33603226
[TBL] [Abstract][Full Text] [Related]
7. A lncRNA identifies
Xu H; Li Z; Kuo CC; Götz K; Look T; de Toledo MAS; Seré K; Costa IG; Zenke M
Elife; 2023 Mar; 12():. PubMed ID: 36916882
[TBL] [Abstract][Full Text] [Related]
8. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
[TBL] [Abstract][Full Text] [Related]
9. Transcription Factor IRF8 Governs Enhancer Landscape Dynamics in Mononuclear Phagocyte Progenitors.
Kurotaki D; Nakabayashi J; Nishiyama A; Sasaki H; Kawase W; Kaneko N; Ochiai K; Igarashi K; Ozato K; Suzuki Y; Tamura T
Cell Rep; 2018 Mar; 22(10):2628-2641. PubMed ID: 29514092
[TBL] [Abstract][Full Text] [Related]
10. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
[TBL] [Abstract][Full Text] [Related]
11. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
[TBL] [Abstract][Full Text] [Related]
12. Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8.
Anderson DA; Ou F; Kim S; Murphy TL; Murphy KM
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34958351
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
Kurotaki D; Kawase W; Sasaki H; Nakabayashi J; Nishiyama A; Morse HC; Ozato K; Suzuki Y; Tamura T
Blood; 2019 Apr; 133(17):1803-1813. PubMed ID: 30796024
[TBL] [Abstract][Full Text] [Related]
14. IRF8-Dependent Type I Conventional Dendritic Cells (cDC1s) Control Post-Ischemic Inflammation and Mildly Protect Against Post-Ischemic Acute Kidney Injury and Disease.
Li N; Steiger S; Fei L; Li C; Shi C; Salei N; Schraml BU; Zheng Z; Anders HJ; Lichtnekert J
Front Immunol; 2021; 12():685559. PubMed ID: 34234783
[TBL] [Abstract][Full Text] [Related]
15.
Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
[TBL] [Abstract][Full Text] [Related]
16. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
17. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.
Kurotaki D; Osato N; Nishiyama A; Yamamoto M; Ban T; Sato H; Nakabayashi J; Umehara M; Miyake N; Matsumoto N; Nakazawa M; Ozato K; Tamura T
Blood; 2013 Mar; 121(10):1839-49. PubMed ID: 23319570
[TBL] [Abstract][Full Text] [Related]
18. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
[TBL] [Abstract][Full Text] [Related]
19. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
[TBL] [Abstract][Full Text] [Related]
20. The Third Intron of IRF8 Is a Cell-Type-Specific Chromatin Priming Element during Mouse Embryonal Stem Cell Differentiation.
Khateb M; Azriel A; Levi BZ
J Mol Biol; 2019 Jan; 431(2):210-222. PubMed ID: 30502383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
